First, take a breath. What you're feeling — the fear, the helplessness, the desperate need to *do something* — is completely understandable. You're already doing the right things by seeking information and preparing for tomorrow's appointments.
Radiation for the spinal tumor is a common and appropriate first step. It's Show Full Answer
First, take a breath. What you're feeling — the fear, the helplessness, the desperate need to *do something* — is completely understandable. You're already doing the right things by seeking information and preparing for tomorrow's appointments.
Radiation for the spinal tumor is a common and appropriate first step. It's used to relieve pain and reduce pressure on the nerves, which is especially important given the compression at L5-S1. The goal right now is protecting his quality of life and preventing further nerve damage. For well-differentiated lung NETs that have spread, treatment options your oncologist may discuss include:
- Targeted therapy — Everolimus (Afinitor) is FDA-approved to slow NET growth, though it typically stabilizes rather than shrinks tumors
- Somatostatin analogs — Medications like octreotide or lanreotide may help control hormone-related symptoms and slow growth (used "off-label" for lung NETs)
- Chemotherapy — Usually considered when tumors are spreading quickly or causing severe symptoms
- Immunotherapy — Can help activate the immune system against cancer cells
- Radiation — Already underway for spinal relief; can also be used elsewhere Here are some important questions to bring to tomorrow's oncology appointment:
1. Is the tumor functional or nonfunctional (does it produce hormones)?
2. What is the Ki-67 index or grade of the tumor? This helps determine how aggressive it is.
3. Is everolimus or a somatostatin analog appropriate for his case?
4. Are there clinical trials available for his specific NET type?
5. What are the goals of treatment — stabilization, shrinkage, or symptom management?
6. How will we monitor treatment response?
7. What symptoms should prompt an urgent call to the care team?
8. Is a palliative care team involved, and how can they help manage pain and quality of life? One encouraging note — well-differentiated lung NETs generally have better survival rates compared to other lung cancers. The five-year relative survival rate for metastatic lung NETs is around 55%, and the overall five-year rate is 89%. That's not a guarantee, but it's meaningful context.
A MyLungCancerTeam member once shared that going into oncology appointments with a written list of questions — and bringing someone to take notes — made a huge difference in feeling less overwhelmed. You're already thinking ahead, and that matters more than you know. 💙
July 19
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
